Status:
RECRUITING
Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women
Lead Sponsor:
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Collaborating Sponsors:
Gilead Sciences
Conditions:
Vulnerable Population
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Globally, women accounted for more than half of people living with HIV (53%) in 2022. In France, 54% of new infections were heterosexual in 2022, 71% of whom were born abroad, mainly in sub-Saharan Af...
Detailed Description
Overall, HIV prevalence among girls and women is higher than that of boys and men since the 2000s. For example, UNAIDS data in 2022 shows that 53% of people living with HIV (PLHIV) are girls and women...
Eligibility Criteria
Inclusion
- Female, 18 years of age or older
- Living in Ile de France
- In a vulnerable situation with at least one of the following two situations:
- Social/economic vulnerability (without personal residence or residence permit of less than 2 years or expiring in less than 1 year or without social security/AME/PUMA (ex CMU)
- Sexual vulnerability: occasional paid sex worker
- Able to understand the objectives of the study
- Having been informed of the study objectives and not opposed to participating in the study.
- Having signed the consent form prior to any examination being performed in the study.
Exclusion
- • Person protected by law, or not in a position to express their consent or subject to a measure of guardianship or safeguard of justice
Key Trial Info
Start Date :
March 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06996938
Start Date
March 21 2025
End Date
June 15 2028
Last Update
May 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pitie-Salpetriere Hospital
Paris, France, 75013
2
IKAMBERE Association
Saint-Denis, Île-de-France Region, France, 93200